In the following video, Motley Fool energy analysts Joel South and Taylor Muckerman discuss another solid quarter for U.S. pipeline company Enterprise Products Partners (NYSE: EPD ) , in which the company increased its distributions for the 35th straight quarter. Joel gives investors several metrics to show not only that the company can continue to support strong dividend growth, but also that its solid backlog and low financing costs mean great prospects for continued, strong growth. He then discusses why Enterprise is a buy, even a better one than some of its high-growth pipeline contemporaries.
The growing production of natural gas from hydraulic fracturing and horizontal drilling is flooding the North American market and resulting in record-low prices for natural gas. Enterprise Products Partners, with its superior integrated asset base, can profit from the massive bottlenecks in takeaway capacity by taking on large-scale projects. To help investors decide whether Enterprise Products Partners is a buy or a sell today, click here now to check out The Motley Fool's brand-new premium research report on the company.
Hot Low Price Companies To Invest In Right Now: Myriad Genetics Inc (MYGN)
Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).
As of June 30, 2012, the Company had launched nine commercial molecular diagnostic tests. The Company markets these tests through its own approximate 385-person sales force in the United States. The Company also markets its BRACAnalysis, COLARIS, and COLARIS AP tests through its own European sales force and have entered into marketing collaborations with other organizations in selected Latin American, European and Asian countries. The Company also generates revenue by providing companion diagnostic services to the pharmaceutical, and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.
Molecular Diagnostic Tests
The Company's molecular diagnostic tests are designed to analyze genes, their mutations, expression levels and proteins to assess an individual's risk for developing disease later in life, determine a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recurrence and measure a patient's exposure to drug therapy to ensu! re optimal dosing and reduced drug toxicity. The Company's BRACAnalysis test is a analysis of the BRCA1 and BRCA2 genes for assessing a woman's risk of developing hereditary breast and ovarian cancer. BRACAnalysis accounted for 81.7% of the Company's total revenue during the fiscal year ended June 30, 2012. Its The Company's COLARIS test is an analysis of the MLH1, MSH2, MSH6 and PMS2 genes for assessing a person's risk of developing colorectal cancer or uterine cancer.
The Company's COLARIS AP test detects mutations in the APC and MYH genes, which cause a colon polyp-forming syndrome known as Familial Adenomatous Polyposis (FAP), a more common variation of the syndrome known as attenuated FAP, and the MYH-associated polyposis signature (MAP). The Company's MELARIS test analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma. The Company's OnDose test is a nanoparticle immunoassay that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients on an individualized basis. The Company's PANEXIA test is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. The Company's PREZEON test is an immunohistochemistry test that analyzes the PTEN gene and assesses loss of PTEN function in many cancer types.
The Company's Prolaris test is a 46-gene molecular diagnostic assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that would warrant aggressive intervention, such as a radical prostatectomy or radiation therapy. The Company's TheraGuide 5-FU test analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of toxicity to 5-FU (fluorouracil) anti-cancer drug therapy.
Companion Diagnostic Services and Other Revenue
! Through M! yriad RBM Inc., the Company provides biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical researches industries utilizing its multiplexed immunoassay technology. The Company's technology enables the Company to screen large sets of clinical samples from both diseased and non-diseased populations against the Company's menu of biomarkers. The Company's companion diagnostic services consist of Multi-Analyte Profile (MAP), Multiplexed Immunoassay Kits and TruCulture.
The Company has compiled a library of over 550 individual human and rodent immunoassays for use in its multi-analyte profile (MAP) testing services. The Company has also developed RodentMAP, a panel for use in pre-clinical animal studies and OncologyMAP, which measures cancer-related proteins to assists researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring. The Company has developed multiplexed immunoassay kits that enable its customers to leverage its technology services with their in-house capabilities. The Company's internally developed multiplexed immunoassay kits include all of the components necessary for a customer to perform a test on their own Luminex instrument. TruCulture is a simple, self-contained whole blood culture that can be deployed to clinical sites around the world for acquiring cell culture data without specialized facilities or training.
Hot Low Price Companies To Invest In Right Now: Nortech Systems Incorporated(NSYS)
Nortech Systems Incorporated operates as a contract manufacturing company. It manufactures wire harness cable and printed circuit board assemblies, electronic sub-assemblies, higher level assemblies, and complete devices. The company also provides value added services and technical support, including design, testing, prototyping, and supply chain management; and repair services on circuit boards used in machines in the medical industry. In addition, it engages in the design, manufacture, and post-production service of electronic and electromechanical medical devices for diagnostic, analytical, and other life-science applications. Nortech Systems Incorporated serves various industries that include aerospace and defense; medical; and the industrial markets, which include industrial equipment, transportation, vision, agriculture, and oil and gas. The company markets its products through sales force and independent manufacturers? representatives. Nortech Systems Incorporated was founded in 1981 and is headquartered in Wayzata, Minnesota.
Top 10 Value Companies To Watch For 2014: Southern National Bancorp of Virginia Inc.(SONA)
Southern National Bancorp of Virginia, Inc. operates as the bank holding company for Sonabank, which provides commercial banking products and services primarily to small and medium-sized businesses, and retail clients in the United States. It offers deposit products, including non-interest-bearing and interest-bearing checking accounts, commercial checking accounts, money market accounts, savings accounts, time deposits, and certificates of deposit. The company also provides commercial mortgage and non-mortgage loans, including commercial real estate loans, construction to permanent loans, development and builder loans, accounts receivable financing, lines of credit, equipment and vehicle loans, leasing, and commercial overdraft protection; small business administration loans and stand-by letters of credit; single family residential construction loans; home equity lines of credit; and secured and unsecured consumer loans primarily for personal, family, or household purpose s. In addition, it offers cash management services, including investment/sweep, zero balance, and controlled disbursement accounts; and wire transfer, employer/payroll processing, night depository, lockbox, depository transfers, merchant, ACH originations, check 21 processing, and asset based lending services. The company?s other consumer/retail products and services include debit and credit cards, ATM services, travelers? checks, savings bonds, notary services, telephone banking, and online banking with bill payment services. As of June 29, 2011, it operated through 13 banking offices in McLean, Front Royal, Fairfax, New Market, Reston, Leesburg, Warrenton, South Riding, Charlottesville, Middleburg, and Clifton Forge County in Virginia, as well as 1 banking office in Rockville, Maryland; and loan production offices in Charlottesville, Fredericksburg, Warrenton, and Richmond in Virginia. The company was founded in 2004 and is headquartered in McLean, Virginia.
Hot Low Price Companies To Invest In Right Now: Stewart Enterprises Inc.(STEI)
Stewart Enterprises, Inc., through its subsidiaries, provides funeral and cemetery products and services in the death care industry in the United States and Puerto Rico. The company also offers a range of funeral merchandise and services, as well as cemetery property, cremation, merchandise, and services. Its funeral homes provide various services and products, including the family consultation, removal and preparation of remains, usage of funeral home facilities for visitation, worship and funeral services, transportation services, flowers, and caskets. The company also sells cemetery property and related merchandise, which includes lots, lawn crypts, family and community mausoleums, monuments, markers, and burial vaults; and provides burial site openings and closings and inscriptions. In addition, it maintains cemetery grounds under cemetery perpetual care contracts and local laws. As of January 31, 2011, the company owned and operated 218 funeral homes and 141 cemeterie s. Stewart Enterprises, Inc. was founded in 1910 and is based in Jefferson, Louisiana.
Hot Low Price Companies To Invest In Right Now: Alliance Resource Partners L.P.(ARLP)
Alliance Resource Partners, L.P. engages in the production and marketing of coal for utilities and industrial users in the United States. It operates nine underground mining complexes, which offer low, medium, and high-sulfur coal. The company also leases land and operates a coal loading terminal on the Ohio River at Mt. Vernon, Indiana; and purchases and resells coal. In addition, the company provides mine products and services comprising design and installation of underground mine hoists for transporting employees and materials in and out of mines; design of systems for automating and controlling various aspects of industrial and mining environments; and design and sale of mine safety equipment, such as its miner and equipment tracking, and proximity detection systems. Further, it offers ash and scrubber sludge removal, coal yard maintenance, and arranging alternate transportation services. As of December 31, 2010, the company had approximately 697.4 million tons of coal reserves in Illinois, Indiana, Kentucky, Maryland, Pennsylvania, and West Virginia. Alliance Resource Management GP, LLC serves as the general partner of Alliance Resource Partners, L.P. The company was founded in 1971 and is based in Tulsa, Oklahoma.
Advisors' Opinion:- [By Bill]
Coal is also an attractive investment to protect investors against runaway inflation. Industrial use of coal is particularly quite high. Flexible electricity producers switch between coal and other energy sources and this causes a high correlation in prices. The price of coal also collapsed from $200 per ton to $60 per ton during the financial crisis. The current level of $120 is 40% lower than its peak price. ARLP is a very profitable company, and it will benefit from the rise in coal prices. Current P/E ratio of 10 and dividend yield of 5% suggests ARLP is a very good buy.
- [By Richard Young]
The market storyline says coal will soon be run to extinction because of new EPA regulations curtailing pollutants and forcing upgrades to scrubbers on coal plants. But the real losers will be small coal power plants with no scrubbers. They’re simply not worth the cost of upgrading. But coal isn’t going anywhere. The driver of growth at U.S. coal mining companies may not be domestic demand, but rather rapidly increasing demand for coal from Asia. China and India are expected to double their energy consumption by 2035. Buy ARLP to gain exposure to the fourth-largest coal producer in the Eastern U.S. My relative strength chart shows ARLP’s long record of outperformance compared to the S&P.
Hot Low Price Companies To Invest In Right Now: Interval Leisure Group Inc.(IILG)
Interval Leisure Group, Inc., together with its subsidiaries, provides membership and leisure services to the vacation industry in the United States, the United Kingdom, and internationally. The company operates through two segments, Membership and Exchange, and Management and Rental. The Membership and Exchange segment offers travel and leisure related products and services to owners of vacation interests, and others primarily through various membership programs, as well as related services to resort developer clients. As of December 31, 2011, its Interval Network comprised approximately 2,600 resorts located in approximately 75 countries, as well as had approximately 1.8 million vacation ownership interest owners enrolled as members. The Management and Rental segment offers hotel, condominium resort, timeshare resort and homeowners association management, and vacation rental services to vacationers and vacation property owners. As of the above date, this segment provided management and rental services to approximately 60 vacation properties and hotels. Interval Leisure Group, Inc. was incorporated in 2008 is headquartered in Miami, Florida.
No comments:
Post a Comment